Related Experiment Video
Updated: Jun 15, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses
Stephen Flowers1, Brenda A Petronella2, Michael S McQueney1
1Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America.
Abstract:
Activation of the cGAS-STING pathway plays a key role in the innate immune response to cancer through Type-1 Interferon (IFN) production and T cell priming. Accumulation of cytosolic double-stranded DNA (dsDNA) within tumor cells and dying cells is recognized by the DNA sensor cyclic GMP-AMP synthase (cGAS) to create the secondary messenger cGAMP, which in turn activates STING (STimulator of INterferon Genes), resulting in the subsequent expression of IFN-related genes. This process is regulated by Three-prime Repair EXonuclease 1 (TREX1), a 3' → 5' exonuclease that degrades cytosolic dsDNA, thereby dampening activation of the cGAS-STING pathway, which in turn diminishes immunostimulatory IFN secretion. Here, we characterize the activity of VB-85680, a potent small-molecule inhibitor of TREX1. We first demonstrate that VB-85680 inhibits TREX1 exonuclease activity in vitro in lysates from both human and mouse cell lines. We then show that treatment of intact cells with VB-85680 results in activation of downstream STING signaling, and activation of IFN-stimulated genes (ISGs). THP1-Dual™ cells cultured under low-serum conditions exhibited an enhanced ISG response when treated with VB-85680 in combination with exogenous DNA. Collectively, these findings suggest the potential of a TREX1 exonuclease inhibitor to work in combination with agents that generate cytosolic DNA to enhance the acquisition of the anti-tumor immunity widely associated with STING pathway activation.
Insights
A novel TREX1 inhibitor, VB-85680, activates the cGAS-STING pathway by preventing DNA degradation. This enhances anti-tumor immunity, particularly when combined with DNA-generating agents.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- The cGAS-STING pathway is crucial for innate immunity against cancer, mediating Type-1 Interferon (IFN) production and T cell priming.
- Cytosolic double-stranded DNA (dsDNA) activates cyclic GMP-AMP synthase (cGAS), which signals STING (STimulator of INterferon Genes) to induce IFN-related gene expression.
- Three-prime Repair EXonuclease 1 (TREX1) degrades cytosolic dsDNA, acting as a negative regulator of the cGAS-STING pathway and reducing IFN secretion.
Purpose of the Study:
- To characterize the activity of VB-85680, a small-molecule inhibitor of TREX1.
- To evaluate the potential of TREX1 inhibition to enhance STING pathway activation and anti-tumor immunity.
Main Methods:
- In vitro enzymatic assays to assess TREX1 inhibition by VB-85680 using human and mouse cell lysates.
- Cell-based assays to measure STING signaling activation and IFN-stimulated gene (ISG) expression in response to VB-85680 treatment.
- Combination studies with exogenous DNA in THP1-Dual™ cells under low-serum conditions.
Main Results:
- VB-85680 effectively inhibited TREX1 exonuclease activity in vitro.
- Treatment with VB-85680 led to the activation of STING signaling and ISG expression in intact cells.
- Combined treatment with VB-85680 and exogenous DNA enhanced the ISG response in THP1-Dual™ cells.
Conclusions:
- VB-85680 is a potent TREX1 inhibitor with the capacity to activate the cGAS-STING pathway.
- TREX1 inhibition holds promise for enhancing anti-tumor immunity, especially in combination with therapies that generate cytosolic DNA.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

